logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Concomitant aspirin with osimertinib offers PFS benefit in EGFR-mutant NSCLC

Benefit was found in both first- or subsequent-line osimertinib use.